AMIT-Technion (The Alfred Mann Institute)

An accelerator based in Haifa, Israel, focused on commercializing biomedical technologies developed by Technion scientists.

Incubator Haifa, Israel Est. 2006
Last updated 2026-11-10
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
1
Rounds' value
$6.5M
total disclosed, rounds participated
Stages
—

About

The Alfred Mann Institute at the Technion (AMIT) is a university-based institute in Haifa, Israel, established in 2006 by American entrepreneur and philanthropist Alfred Mann and the Technion – Israel Institute of Technology. Its mission is to bridge the gap between academic biomedical research and commercial success by supporting the development and commercialization of innovative biomedical technologies that improve human health. AMIT acts as an acceleration hub for innovations conceived by Technion students, faculty, and alumni.

Portfolio · 2

Q&A

What is the primary focus of AMIT-Technion?
AMIT-Technion is an accelerator based in Haifa, Israel, focused on commercializing biomedical technologies developed by Technion scientists.
When was AMIT-Technion established?
AMIT-Technion was established in 2006 by American entrepreneur and philanthropist Alfred Mann and the Technion – Israel Institute of Technology.
What is AMIT-Technion's mission?
Its mission is to bridge the gap between academic biomedical research and commercial success by supporting the development and commercialization of innovative biomedical technologies that improve human health.
What is AMIT-Technion's preferred sector for investments?
AMIT-Technion primarily focuses on the Health Tech & Life Sciences sector.
What is the total AUM for AMIT-Technion?
AMIT-Technion has a total AUM of $100,000,000.
Which fund does AMIT-Technion manage?
AMIT-Technion manages the Alfred Mann Institute at the Technion Endowment, established in 2006 with a size of $100,000,000.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2006